NCT05932901View on ClinicalTrials.gov

OPTIMISE-CKD Drug Utilization

CompletedOBSERVATIONAL

Enrollment

2,682,052

Participants

Timeline

Start Date

May 4, 2022

Primary Completion Date

September 28, 2023

Study Completion Date

September 28, 2023

Conditions

Chronic Kidney Disease

Trial Locations (5)

13625

Research Site, Minneota

75320

Research Site, Uppsala

75322

Research Site, Uppsala

604-0086

Research Site, Kyoto

101-0053

Research Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY